Peanut Placebo, Nocebo, PCSK9: Lipid lowering and peanut allergy
Mar 21, 2015•29 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week: New studies of PCSK9 inhibitors for lipid lowering and a randomized controlled trial of early peanut exposure to prevent allergy Fahad and Amol want you to understand the following: 1. PCSK9 inhibitors are new cholesterol-lowering monoclonal antibodies that have been shown to reduce LDL beyond standard therapy with statins and have been associated with reduced ...
The post Peanut Placebo, Nocebo, PCSK9: Lipid lowering and peanut allergy appeared first on Healthy Debate.
For the best experience, listen in Metacast app for iOS or Android